高血压急症如何处理?来看最新中国专家共识!

2022-04-27 中华高血压杂志 中华高血压杂志

高血压急症是急诊科、心血管科及很多临床科室经常面对的急危重症之一,起病急、预后转归变化大、病死率高是主要临床特点。为统一高血压急症的定义、诊断和治疗标准,规范临床诊治,改善患者预后及生活质量,中国医师

高血压急症是急诊科、心血管科及很多临床科室经常面对的急危重症之一,起病急、预后转归变化大、病死率高是主要临床特点。为统一高血压急症的定义、诊断和治疗标准,规范临床诊治,改善患者预后及生活质量,中国医师协会高血压专业委员会参考相关文献及指南起草了《高血压急症的问题中国专家共识》。
 
以下是该指南要点内容:
 
图片
图片
图片
图片
图片
图片
图片
图片
图片
图片
图片
图片

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1649297, encodeId=fb78164929ed3, content=<a href='/topic/show?id=1c8152531f0' target=_blank style='color:#2F92EE;'>#急症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52531, encryptionId=1c8152531f0, topicName=急症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c33023794178, createdName=wjywjy, createdTime=Tue Mar 28 14:45:52 CST 2023, time=2023-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845921, encodeId=ccbc184592170, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Tue Jul 26 12:45:52 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736390, encodeId=05a31e363903c, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Thu Jul 28 01:45:52 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741685, encodeId=14431e4168532, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sun May 08 01:45:52 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624161, encodeId=89d816241610e, content=<a href='/topic/show?id=965c1026e4d0' target=_blank style='color:#2F92EE;'>#高血压急症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102674, encryptionId=965c1026e4d0, topicName=高血压急症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176220654398, createdName=wrj0128, createdTime=Fri Apr 29 04:45:52 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2023-03-28 wjywjy
  2. [GetPortalCommentsPageByObjectIdResponse(id=1649297, encodeId=fb78164929ed3, content=<a href='/topic/show?id=1c8152531f0' target=_blank style='color:#2F92EE;'>#急症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52531, encryptionId=1c8152531f0, topicName=急症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c33023794178, createdName=wjywjy, createdTime=Tue Mar 28 14:45:52 CST 2023, time=2023-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845921, encodeId=ccbc184592170, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Tue Jul 26 12:45:52 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736390, encodeId=05a31e363903c, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Thu Jul 28 01:45:52 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741685, encodeId=14431e4168532, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sun May 08 01:45:52 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624161, encodeId=89d816241610e, content=<a href='/topic/show?id=965c1026e4d0' target=_blank style='color:#2F92EE;'>#高血压急症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102674, encryptionId=965c1026e4d0, topicName=高血压急症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176220654398, createdName=wrj0128, createdTime=Fri Apr 29 04:45:52 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1649297, encodeId=fb78164929ed3, content=<a href='/topic/show?id=1c8152531f0' target=_blank style='color:#2F92EE;'>#急症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52531, encryptionId=1c8152531f0, topicName=急症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c33023794178, createdName=wjywjy, createdTime=Tue Mar 28 14:45:52 CST 2023, time=2023-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845921, encodeId=ccbc184592170, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Tue Jul 26 12:45:52 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736390, encodeId=05a31e363903c, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Thu Jul 28 01:45:52 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741685, encodeId=14431e4168532, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sun May 08 01:45:52 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624161, encodeId=89d816241610e, content=<a href='/topic/show?id=965c1026e4d0' target=_blank style='color:#2F92EE;'>#高血压急症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102674, encryptionId=965c1026e4d0, topicName=高血压急症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176220654398, createdName=wrj0128, createdTime=Fri Apr 29 04:45:52 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
    2022-07-28 贵阳
  4. [GetPortalCommentsPageByObjectIdResponse(id=1649297, encodeId=fb78164929ed3, content=<a href='/topic/show?id=1c8152531f0' target=_blank style='color:#2F92EE;'>#急症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52531, encryptionId=1c8152531f0, topicName=急症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c33023794178, createdName=wjywjy, createdTime=Tue Mar 28 14:45:52 CST 2023, time=2023-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845921, encodeId=ccbc184592170, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Tue Jul 26 12:45:52 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736390, encodeId=05a31e363903c, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Thu Jul 28 01:45:52 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741685, encodeId=14431e4168532, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sun May 08 01:45:52 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624161, encodeId=89d816241610e, content=<a href='/topic/show?id=965c1026e4d0' target=_blank style='color:#2F92EE;'>#高血压急症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102674, encryptionId=965c1026e4d0, topicName=高血压急症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176220654398, createdName=wrj0128, createdTime=Fri Apr 29 04:45:52 CST 2022, time=2022-04-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1649297, encodeId=fb78164929ed3, content=<a href='/topic/show?id=1c8152531f0' target=_blank style='color:#2F92EE;'>#急症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52531, encryptionId=1c8152531f0, topicName=急症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c33023794178, createdName=wjywjy, createdTime=Tue Mar 28 14:45:52 CST 2023, time=2023-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1845921, encodeId=ccbc184592170, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Tue Jul 26 12:45:52 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736390, encodeId=05a31e363903c, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Thu Jul 28 01:45:52 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741685, encodeId=14431e4168532, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sun May 08 01:45:52 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1624161, encodeId=89d816241610e, content=<a href='/topic/show?id=965c1026e4d0' target=_blank style='color:#2F92EE;'>#高血压急症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102674, encryptionId=965c1026e4d0, topicName=高血压急症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176220654398, createdName=wrj0128, createdTime=Fri Apr 29 04:45:52 CST 2022, time=2022-04-29, status=1, ipAttribution=)]

相关资讯

郭艺芳&袁静:硝苯地平不宜用于紧急降压

硝苯地平是一种重要降压药物,多年以来一直广泛应用于临床。由于短效硝苯地平作用持续时间短,需每日多次用药,且可导致血压明显波动,近年来其临床应用有所减少,逐渐被硝苯地平控释或缓释剂型所取代。但因价格低廉且起效快,该药在基层医疗机构仍较多使用。很多医生常将舌下含服短效硝苯地平用于高血压急症、亚急症或一般高血压患者的紧急降压,这种用药方法可能会对患者产生严重不利影响,应予避免。 1. 短效硝苯地平

高血压的终身治疗方案

为配合基层医院诊疗条件的特点, 普及和提高基层医生的慢性疾病防治水平, 胡大一教授倡议并牵头组织了中国县医院联盟, 2014 年面向基层医生推出《中国慢性疾病防治基层医生诊疗手册》。 为此, 本刊为《手册》开辟专栏, 冀望提高基层医生对患者高血脂、高血压、心律失常、高血糖等的诊断和治疗能力, 及对患者的整体疾病管理水平。 --------------------- 高血压

高血压急症及围术期高血压调研

本调研由梅斯医学发起,旨在了解高血压急症的治疗现状,以优化治疗药物的选择和应用。

OCC 2020:许顶立教授介绍高血压急症治疗

南方医科大学南方医院 许顶立 教授

有奖:高血压急症及围术期高血压调研

伴随经济增长和居民生活水平的持续提高,我国心血管疾病的发病率呈现“一高一低”的态势:发病率高、患者年龄趋低(年轻化)。如何有效预防和管理心血管疾病,如何在诊疗过程中提高效率,做